Ghiglioni, D.G.; Martino, P.A.; Bruschi, G.; Vitali, D.; Osnaghi, S.; Corti, M.G.; Beretta, G.
Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach. Pharmaceutics 2020, 12, 378.
https://doi.org/10.3390/pharmaceutics12040378
AMA Style
Ghiglioni DG, Martino PA, Bruschi G, Vitali D, Osnaghi S, Corti MG, Beretta G.
Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach. Pharmaceutics. 2020; 12(4):378.
https://doi.org/10.3390/pharmaceutics12040378
Chicago/Turabian Style
Ghiglioni, Daniele Giovanni, Piera Anna Martino, Gaia Bruschi, Davide Vitali, Silvia Osnaghi, Maria Grazia Corti, and Giangiacomo Beretta.
2020. "Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach" Pharmaceutics 12, no. 4: 378.
https://doi.org/10.3390/pharmaceutics12040378
APA Style
Ghiglioni, D. G., Martino, P. A., Bruschi, G., Vitali, D., Osnaghi, S., Corti, M. G., & Beretta, G.
(2020). Stability and Safety Traits of Novel Cyclosporine A and Tacrolimus Ophthalmic Galenic Formulations Involved in Vernal Keratoconjunctivitis Treatment by a High-Resolution Mass Spectrometry Approach. Pharmaceutics, 12(4), 378.
https://doi.org/10.3390/pharmaceutics12040378